The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
I read what TW said. However, if the money enables AVO bring LIGHT to market and it succeeds, why can't AVO dump the agreement like Valirx did when it's no longer needed?
Whoever it is doesn't seem to agree with the derampers.
This is not bad news because we all knew that AVO was desperate for cash and had to do something about it.. What this means that AVO should now have the wherewithal to complete testing, begin manufacturing and bring Harley Street on line.
SMTrading. Out of hours trading is very commonplace. Anyone, including you or me can do it. It has no implications attached to it just because it is out of hours. This evening's trade was for a mere 1171 shares at 71p, amounting to £831.
I would have thought that non-dilutive ruled out a placement.
SMTrading. It's anyone's guess.
After hours trades are very common, including on AVO, so nothing to comment about. The ones to watch for are the ones over a hundred thousand shares, perhaps a few hundred thousand, no matter what time of day they happen. There haven't been many of those recently.
In the Operational Update RNS of 30/11/16, Nicolas Serandour said: "We are aware of investors' concerns over a more detailed roadmap for the final stages of development and installation at our first site and I expect to be in a position to outline these to shareholders in Q1 2017." I assume that is the purpose of the presentation.
Maybe Zurich because AVO's research establishment is in Switzerland.
That might be involved but there could be other reasons. China is a very authoritarian country and managers who fail to perform stand to lose far more than just their jobs. The pressures for the hospitals to meet their construction targets would be enormous. It means that faced with a choice between a proton therapy system from small little company without a finished product and an established company that says it can guarantee delivery on time, the managers responsible for the Hospital development had little choice but to cancel the AVO deal. Sinophi is experienced in the ways of China so can be expected to have gone with the flow to protect themselves. Sinophi would be anxious to keep in with the Chinese. It might be all about Chinese politics and little else. AVO would be equally keen to keep things sweet for themselves in China and not make enemies or appear a difficult company to deal with. It would explain AVO's readiness to reach an amicable settlement and repay the cash. It would be about not burning boats, not making enemies in China and about keeping doors open for the future.
The chart is showing a definite 'W' pattern. That is often followed by a rise.
That is interesting. When I first read it, or a previous version of it, a couple of years or so ago, coupled with what AVO said in their Investors' Day Presentation in November 2014, I was under the impression it meant that hospitals would buy just one standard LIGHT machine that they would be able to adjust to the needs of the treatment the patient required. It seemed to make sense. In fact, it still makes more sense to me that it should be so, otherwise we could be talking about a hospital having, perhaps, multiple LIGHT machines, each one for a different type of cancer depending on the number of modules in each machine. Alternatively, they might decide at the outset what types of cancer they would treat and buy a LIGHT machine that could only treat those types of cancer. Just thinking out loud really. The conclusion I have come to is the most hospitals would probably go for a standard machine that could treat a variety of cancers by themselves varying the beam. That is in fact what I thought AVO was offering, although I could imagine AVO also selling a specialist eye hospital a machine that might only be able to treat eye cancers.
Archbishop. Please post a link to where AVO says what you have posted. I cannot recall seeing that said before.
kenj I have heard reports about similar events concerning other AIM companies in the past but never about the regulators doing anything about it. Is it the case that the regulators are not interested unless something goes wrong with a company?
Exactly so 938MeV. But try telling that to TW and some others. The nearest I've heard of to something approaching what AVO has is recent research in the USA into laser beams that are directed through an appropriate substance to produce a proton beam. The Americans hope that they might, one day, be able develop that into a cheap and compact linear proton therapy machine. It demonstrates just how far ahead of the pack AVO is.
AParky. If you think that those on this forum are bad, you should look at the ADVFN forum.
The market seems to have given him the thumbs up this afternoon.
938MeV. Perhaps it's worth pointing out that LIGHT does not use a synchrotron either.
Kenj. It is very easy to say that someone should know something, especially if they are obviously very intelligent but, in my experience, many people, very intelligent or not, don't necessarily understand details that other people with different expertise consider obvious. Do you know everything you should know? If you do you are unusual. He might not have given a second thought to the ramifications when he bought, especially if his mind was on something like his next operation. It happens.
On the other hand, perhaps you are trying to make something out of nothing?